Skip to content
Stop using now Drug recall · FDA · Published June 3, 2015

Baxter Recalls Heparin Sodium Due to Subpotent Drug Risk

Baxter Healthcare recalls specific lots of Heparin Sodium and 0.9% Sodium Chloride Injection due to subpotent drug issues. Check lot numbers N002998, N003004, and N003038.

🇺🇸 FDA recall #D-1131-2015DrugBaxter Healthcare Corp. ›
Take action

Contact the company

Recalling firmBaxter Healthcare Corp1 Baxter Pkwy · Deerfield, IL 60015-4625
✎ GovInfoNow plain-language explainer

What happened, in plain English

Baxter Healthcare Corp. is recalling specific lots of Heparin Sodium and 0.9% Sodium Chloride Injection because the heparin raw material resulted in subpotent drug levels that are out of specification. This means the medication may not provide the expected therapeutic effect for patients who rely on it to prevent or treat blood clots. The recall affects 145,350 containers distributed nationwide. Read more at govinfonow.com/recall/44209-baxter-healthcare-corp-recalls-heparin-sodium-and-0-9-sodium.

Source Summary by GovInfoNow · govinfonow.com/recall/44209-baxter-healthcare-corp-recalls-heparin-sodium-and-0-9-sodium · Updated October 12, 2026 · FDA enforcement record: FDA #D-1131-2015

Cite this page

“Baxter Recalls Heparin Sodium Due to Subpotent Drug Risk.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44209-baxter-healthcare-corp-recalls-heparin-sodium-and-0-9-sodium. Based on FDA recall #D-1131-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1131-2015%22&limit=1).

Why it’s dangerous

The hazard is that the drug is subpotent due to out-of-specification results for the heparin raw material. If the concentration of heparin is lower than labeled, it may fail to adequately prevent or treat blood clots, leading to potential serious medical complications.

Who’s affected

Patients prescribed Heparin Sodium and 0.9% Sodium Chloride Injection by Baxter Healthcare Corp. are affected. Individuals relying on this specific medication for anticoagulation therapy are at risk of receiving a subpotent dose.

How to tell if you have this one

Look for Heparin Sodium and 0.9% Sodium Chloride Injection in a VIAFLEX Plus Container, Rx Only. Check the NDC 0338-0431-03 and Product Code 280953. Affected lots are N002998 (exp 12/31/15), N003004 (exp 12/31/15), and N003038 (exp 01/31/2016).

  • Brand
    Baxter Healthcare Corp.
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Lot Numbers

    Verify if your medication matches the recalled lots N002998, N003004, or N003038 with expiration dates of 12/31/15 or 01/31/2016.

  2. Contact Healthcare Provider

    If you have the recalled product, contact your healthcare provider immediately for instructions on replacement or alternative treatment.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

1. Firm started the recall: Jun 3, 201512. FDA classified it Class II: Jun 9, 201523. Published in FDA’s Enforcement Report: Jun 17, 201534. FDA terminated the recall: Mar 14, 2017420152017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

How many containers are being recalled?

A total of 145,350 containers are included in this recall.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1131-2015 (June 3, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1131-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA